Tudor Investment Corp ET AL Invests $1.32 Million in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Tudor Investment Corp ET AL bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,836 shares of the company's stock, valued at approximately $1,315,000.

Several other institutional investors have also modified their holdings of the business. Kestra Investment Management LLC purchased a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $27,000. CIBC Private Wealth Group LLC boosted its stake in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the last quarter. Headlands Technologies LLC bought a new position in Prestige Consumer Healthcare during the 4th quarter valued at $40,000. Johnson Financial Group Inc. acquired a new position in Prestige Consumer Healthcare during the 4th quarter worth $93,000. Finally, GAMMA Investing LLC increased its position in shares of Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock worth $108,000 after purchasing an additional 220 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock traded up $0.61 during mid-day trading on Friday, hitting $87.65. 405,208 shares of the company's stock traded hands, compared to its average volume of 295,917. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The firm has a 50 day moving average price of $83.11 and a 200 day moving average price of $81.22. The company has a market cap of $4.34 billion, a PE ratio of 20.53, a price-to-earnings-growth ratio of 2.69 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The company's revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.02 earnings per share. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. DA Davidson lifted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday. StockNews.com upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Tuesday, April 29th. Finally, Canaccord Genuity Group lifted their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $93.33.

Insider Activity

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.